The 3-year overall survival (OS) and progression-free survival (PFS) were 41% and 21%, respectively. Adverse OS was associated with chemoresistant disease ( ...
We report the outcome of 229 patients who received an allograft for myeloma with reduced-intensity conditioning (RIC) regimens from 33 centers within the ...
Jun 1, 2005 · With a median follow-up of 28 months, 115 patients are alive (range, 1-53 months). The estimated overall survival at 3 years is 40.6% (CI, 33%- ...
The 3-year overall survival (OS) and progression-free survival (PFS) were 41% and 21%, respectively. Adverse OS was associated with chemoresistant disease ( ...
Grades II to IV acute graft-versus-host disease (aGvHD) occurred in 31%. Chronic GvHD was associated with better OS and PFS and were 84% and 46% for limited, 58 ...
Overall, 12 patients (23%) achieved CR and 26 patients (51%) achieved PR, with an overall response rate of 74% after RIC allo-HSCT. Three patients (6%) had ...
People also ask
What is the best prognostic factor for multiple myeloma?
What is the prognosis for multiple myeloma and stem cell transplant?
What is a poor prognostic feature of multiple myeloma?
What is the prognostic test for multiple myeloma?
Nov 1, 2005 · The overall survival (OS) and progression-free survival (PFS) at 3 years were 58% (CI, 50%-66%) and 37% (CI, 30%-45%), respectively.
Missing: multiple myeloma
Overall, 12 patients (23%) achieved CR and 26 patients (51%) achieved PR, with an overall response rate of 74% after RIC allo-HSCT. Three patients (6%) had ...
Comparison of Outcomes of Allogeneic Hematopoietic Cell ...
www.astctjournal.org › article › fulltext
There was no impact in myeloma survival outcomes by conditioning regimen intensity for allogeneic stem cell transplantation.
Aug 18, 2023 · This study demonstrates overall poor survival outcomes in patients who underwent allo SCT for treatment of multiple myeloma with long-term ...
Missing: Leukaemia | Show results with:Leukaemia